UCSF The Medical Management of AIDS and Key Infections
In-Person and Virtual Options available: December 11 - 12, 2025
**Fully Virtual on December 13, 2025 for all attendees**
Course #MDM26K02
Presented by HIV, ID, and Global Medicine Division
Zuckerberg San Francisco General Hospital and Trauma Center
Department of Medicine, University of California, San Francisco
Overview
This course provides the active, intermediate-to-advanced clinician with a comprehensive review of the science of HIV and key infections including HCV, HBV, RSV, H5N1 and COVID, as well as an update on the application of appropriate therapies. Safe and effective use of antiretroviral therapy for both prevention of HIV and treatment of HIV is an indispensable foundational skill which this course emphasizes. Providing successful care for people living with HIV/AIDS in 2025 also involves understanding and treating myriad co-morbid conditions in the fields of cardiology, gastroenterology, endocrinology, dermatology, neurology, behavioral medicine, and addiction medicine. Close collaboration with other specialists and diverse teams of health professionals is vital for the best care of our complex patients.
For ambitious new clinicians who want a challenge, we still offer our New Clinicians Track (NCT). This track provides five additional lectures that cover antiretroviral therapy (ART) 101, basic HIV pharmacology, management of ART resistance, IRIS, and opportunistic infections.
All course lecturers are leading clinicians and or researchers who are dedicated to teaching in their areas of expertise.
Acute and Long COVID continue to amplify existing health disparities and contribute to the vulnerability of all of our patients, making the need for up-to-date information about HIV/AIDS and other key infections crucial for providing high quality care. Current treatment options for acute COVID and understanding the science and management of Long COVID will be addressed.
All lectures will be cased-based with multiple audience response system (ARS) questions per session. Question and answer time as well as faculty panels are woven into each conference day. These interdisciplinary faculty panels are designed with extra ARS questions and allow you to privately test your individual knowledge against our experts throughout the conference. Questions that arise in the Chat will be answered each day by our dedicated faculty. The syllabus will be available for a year and recordings of the conference available for 90 days. This course will be available both in person at the Mission Bay Conference Center and will also be streaming online.
TARGET AUDIENCE
This course is co-chaired by Drs. Diane Havlir, Annie Luetkemeyer and Meg Newman. It is well designed for practicing internists, family practice physicians, infectious disease specialists, nurse practitioners, physician assistants and pharmacists. For three days, we will focus on the breadth of practical issues in the care of people living with HIV/AIDS, hepatitis, RSV, H5N1, COVID and other key infections.
The course is presented by the HIV, ID and Global Medicine Division, Zuckerberg San Francisco General Hospital and Trauma Center, Department of Medicine and is sponsored by the Office of Continuing Medical Education, University of California, San Francisco.
Onsite and Remote Learning Options:
The course will be offered as a live conference. Registrants have the option to attend in person or to tune in remotely via zoom live stream during programming hours (Pacific Time). Login instructions along with the digital syllabus will be shared with attendees before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference (in person or remotely) to claim CME.
**Fully Virtual on December 13, 2025 for all attendees**
Objectives
An attendee completing this course will be able to improve skills and strategies to:
- Diagnose, treat, and prevent important conditions in HIV medicine and HIV medicine subspecialties, for improved patient outcomes;
- Apply in practice the latest treatment guidelines and recommendations for the prevention of HIV transmission and the appropriate use of PEP, PrEP and DoxyPEP including the use of long-acting options;
- Apply new recommendations for initiating and timely switching of antiretroviral combinations including long-acting ART in appropriate patients;
- Identify new developments and apply treatment recommendations in HIV related, dermatologic, metabolic, cardiovascular, and addiction medicine;
- Diagnose and apply new recommendations for the treatment of HBV, HCV, cirrhosis, MASH and MASLD;
- Align practice patterns more with current evidence and guidelines for treating STI’s and HIV;
- Apply in practice the latest transmission prevention guidelines for COVID, Influenza, and RSV as well as the updated treatment guidelines for COVID, Influenza and RSV
- Apply new recommendations for appropriate treatment of acute COVID-19 and Long COVID